Archive
All News
Every briefing, headline, and filing we've published, newest first.
DealsBioPharma Dive ↗
A Jefferies analyst argued the deal — Teva’s largest in a decade — “makes se…
DealsBriefing
Chiesi has announced a $1.9B acquisition of KalVista Pharmaceuticals, continuing 2026’s brisk deal pace among …
PipelinePharmaVoice ↗
Results show a landmark change that could double survival rates in one of the most difficult oncology diagnose…
PolicyFierceBiotech ↗
The FDA today announced a new initiative to allow its reviewers to access information from clinical trials in …
PolicyFiercePharma ↗
Eleventh-hour settlements with two of the three generic drugmakers involved could bode well for both Pfizer an…
DealsBriefing
Lilly’s $2.3 billion move for Ajax Therapeutics centers on a Type II JAK2 inhibitor it helped incubate, aiming…
The WeekEndpoints News ↗
A few years in, admin tech is still reigning as the king of health tech funding. Startups using AI to tackle m…
PolicyEndpoints News ↗
When the Supreme Court hears arguments this week over a prescription-strength pill derived from fish oil, the …
PipelineBioPharma Dive ↗
Survodutide spurred weight loss Wall Street analysts referred to as “Wegovy-like,” and showed sign…
PolicySTAT News ↗
The Supreme Court Wednesday will hear oral arguments about a simmering controversy over so-called skinny label…
DealsPharmaVoice ↗
The large AI player is paying $400 million for the tiny startup, signaling a potential shift in how tech is ap…
DealsFiercePharma ↗
Already the largest biopharma company in India, generics powerhouse Sun Pharma has doubled in size with its ac…
PipelineFierceBiotech ↗
Oruka Therapeutics’ long-acting plaque psoriasis candidate cleared the skin of 63.5% of patients in a phase 2a…
PipelineBriefing
Intellia’s hereditary angioedema therapy cut swelling attacks by 87% in phase 3, positioning the biotech for t…
PolicySTAT News ↗
The Supreme Court seemed divided Monday over whether to block thousands of lawsuits alleging the maker of the …
PipelineEndpoints News ↗
Veradermics has succeeded in its first major test as a newly-minted public company. The biotech's form of oral…
DealsFiercePharma ↗
Merck & Co.’s $1 billion deal with Google Cloud is seeking to bolster its AI credentials—and the U.S. Big …
DealsFierceBiotech ↗
McKesson has let go of a minority share of its medical/surgical solutions division for $1.25 billion to Apollo…
Money
As peers spent $29B in late-March M&A, Roche CEO Thomas Schinecker said high rates, no patent cliffs, and 19 d…
DealsEndpoints News ↗
Indian drug giant Sun Pharma has lined up an $11.75 billion acquisition of Organon, a women’s health and biosi…
PolicyFierceBiotech ↗
The FDA is awarding national priority vouchers to Compass Pathways, Usona Institute and Transcend Therapeutics…
PipelineFiercePharma ↗
After a series of setbacks for Sanofi’s tolebrutinib, the French company has scored a victory for the multiple…
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.